RIGEL PHARMACEUTICALS, INC. Material Contracts
Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.
- 2026-08-04: Form 10-Q; Exhibit 10.6; Description License Agreement, dated May 11, 2026, among Rigel Pharmaceuticals, Inc., Arvinas, Inc., Arvinas Operations, Inc., Arvinas Estrogen Receptor, Inc., and Pfizer Inc..
- 2026-08-04: Form 10-Q; Exhibit 10.5; Description Amendment 1 to Amended and Restated Credit, Security and Guarantee Agreement, dated May 11, 2026, among Rigel Pharmaceuticals, Inc., and MidCap Funding IV Trust, as agent and lender, and the additional lenders from time to time party thereto..
- 2026-08-04: Form 10-Q; Exhibit 10.4; Description Amended and Restated Credit, Security and Guarantee Agreement, dated May 5, 2026, among Rigel Pharmaceuticals, Inc., and MidCap Funding IV Trust, as agent and lender, and the additional lenders from time to time party thereto..
- 2026-08-04: Form 10-Q; Exhibit 10.3; Description Rigel Pharmaceuticals, Inc. 2000 Employee Stock Purchase Plan, as amended..
| Filed | Form | Exhibit | Description |
|---|
| 2026-08-04 | 10-Q | 10.6 | License Agreement, dated May 11, 2026, among Rigel Pharmaceuticals, Inc., Arvinas, Inc., Arvinas Operations, Inc., Arvinas Estrogen Receptor, Inc., and Pfizer Inc. |
|---|
| 2026-08-04 | 10-Q | 10.5 | Amendment 1 to Amended and Restated Credit, Security and Guarantee Agreement, dated May 11, 2026, among Rigel Pharmaceuticals, Inc., and MidCap Funding IV Trust, as agent and lender, and the additional lenders from time to time party thereto. |
|---|
| 2026-08-04 | 10-Q | 10.4 | Amended and Restated Credit, Security and Guarantee Agreement, dated May 5, 2026, among Rigel Pharmaceuticals, Inc., and MidCap Funding IV Trust, as agent and lender, and the additional lenders from time to time party thereto. |
|---|
| 2026-08-04 | 10-Q | 10.3 | Rigel Pharmaceuticals, Inc. 2000 Employee Stock Purchase Plan, as amended. |
|---|
| 2026-08-04 | 10-Q | 10.2 | Rigel Pharmaceuticals, Inc. Inducement Plan, as amended. |
|---|
| 2026-08-04 | 10-Q | 10.1 | Rigel Pharmaceuticals, Inc. 2018 Equity Incentive Plan, as amended. |
|---|
| 2026-03-03 | 10-K | 10.9 | Rigel Pharmaceuticals, Inc. Inducement Plan, as amended. |
|---|